# Dexamethasone in Controlling Dyspnea in Patients With Cancer

> **NCT03367156** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 135 (actual)

## Conditions studied

- Dyspnea
- Malignant Neoplasm

## Interventions

- **DRUG:** Dexamethasone
- **OTHER:** Placebo
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT03367156
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-12-04
- **Primary completion:** 2021-05-05
- **Final completion:** 2025-12-31
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2025-11-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03367156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03367156, "Dexamethasone in Controlling Dyspnea in Patients With Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03367156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*